Real-time continuous glucose monitoring (rt-CGM) reduced large-for-gestational-age (LGA) births in women with gestational diabetes.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Topline data were announced from a phase 3 trial evaluating ersodetug in patients aged 3 months to 45 years with congenital hyperinsulinism.

Higher body dissatisfaction was linked to more severe eating disorder, depressive symptoms in monozygotic and dizygotic twin difference analyses. HealthDay News — Body dissatisfaction may causally ...

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

A data monitoring committee recommended stopping the phase 3 trials of efgartigimod in thyroid eye disease due to lack of efficacy.

Giredestrant shows significant improvement in iDFS in patients with early-stage, HR-positive, HER2-negative breast cancer.

A rapid, user-friendly, highly accurate sensitive molecular test has been developed for diagnosing hepatitis C virus (HCV).

The progression to T2D or cancer and the probability of death following prediabetes diagnosis vary according to age at prediabetes diagnosis, with most younger individuals remaining in the prediabetes ...

Withdrawal of tirzepatide treatment in adults with obesity who have achieved initial weight loss is associated with substantial weight regain and a corresponding reversal of the positive ...